Two publications from the last week:

• Efficacy and economics of targeted panel versus whole exome sequencing in 878 patients with suspected primary immunodeficiency | link
• Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient Values | link

I’m happy to share any other publications from this week that I’ve missed – just let me know.